{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:01:42Z","timestamp":1793138502733,"version":"4.5.0"},"reference-count":128,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Bipolar disorder (BD) is a recurrent and disabling psychiatric disorder related to low-grade peripheral inflammation and altered levels of the members of the insulin-like growth factor (IGF) family. The aim of this study was to evaluate the plasma levels of IGF-2, insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, IGFBP-5, IGFBP-7, and inflammatory markers such as tumor necrosis factor \u03b1 (TNF-\u03b1), monocyte chemoattractant protein 1 (MCP-1), and macrophage inflammatory protein 1\u03b2 (MIP-1\u03b2).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We used the Young Mania Rating Scale (YMRS) to determine the severity of the symptomatology, while proteins were measured by enzyme-linked immunosorbent assay (ELISA). We included 20 patients with BD who suffered a manic episode and 20 controls. Some BD patients (<jats:italic>n<\/jats:italic> = 10) were evaluated after a period (17 \u00b1 8\u00a0days) of pharmacological treatment.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> No statistical difference was found in IGF-2, IGFBP-1, IGFBP-7, TNF-\u03b1, and MIP-1\u03b2 levels. However, IGFBP-3 and IGFBP-5 levels were found to be statistically decreased in BD patients. Conversely, the MCP-1 level was significantly increased in BD patients, but their levels were normalized after treatment. Intriguingly, only IGFBP-1 levels were significantly decreased after treatment. No significant correlation was found between the YMRS and any of the proteins studied either before or after treatment or between IGF proteins and inflammatory markers.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> To some extent, IGFBP-3 and IGFBP-5 might be further explored as potential indicators of treatment responsiveness or diagnosis biomarkers in BD.<\/jats:p>","DOI":"10.3389\/fphar.2024.1384198","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T04:25:02Z","timestamp":1713932702000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients"],"prefix":"10.3389","volume":"15","author":[{"given":"Carlos","family":"Fern\u00e1ndez-Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ar\u00e1nzazu","family":"Penedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Alonso-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Rivera-Baltan\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Vi\u00e9itez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Prieto-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Vilari\u00f1o-Vilari\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saida","family":"Ortolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Carlos","family":"Ag\u00eds-Balboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.tins.2023.03.007","article-title":"IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases","volume":"46","author":"Alberini","year":"2023","journal-title":"Trends Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fendo.2018.00117","article-title":"IGF-binding proteins: why do they exist and why are there so many?","volume":"9","author":"Allard","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"T11","DOI":"10.1530\/JME-17-0254","article-title":"IGF-binding proteins","volume":"61","author":"Bach","year":"2018","journal-title":"J. Mol. Endocrinol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jad.2014.05.009","article-title":"Comparison of inflammatory cytokine levels among type I\/type II and manic\/hypomanic\/euthymic\/depressive states of bipolar disorder","volume":"166","author":"Bai","year":"2014","journal-title":"J. Affect Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00406-010-0116-z","article-title":"Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder","volume":"261","author":"Barbosa","year":"2011","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jpsychires.2011.11.010","article-title":"Increased levels of adipokines in bipolar disorder","volume":"46","author":"Barbosa","year":"","journal-title":"J. Psychiatr. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jad.2011.12.034","article-title":"Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers","volume":"137","author":"Barbosa","year":"","journal-title":"J. Affect Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jpsychires.2014.04.017","article-title":"Inflammatory mediators of cognitive impairment in bipolar disorder","volume":"56","author":"Bauer","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"ITC97","DOI":"10.7326\/AITC202207190","article-title":"Bipolar disorder","volume":"175","author":"Bauer","year":"2022","journal-title":"Ann. Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jad.2020.03.073","article-title":"Increased inflammatory biomarkers and changes in biological rhythms in bipolar disorder: a case-control study","volume":"271","author":"Bavaresco","year":"2020","journal-title":"J. Affect Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3390\/ijms22041849","article-title":"Insulin-like growth factor 2 as a possible neuroprotective agent and memory enhancer-its comparative expression, processing and signaling in mammalian CNS","volume":"22","author":"Beletskiy","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B127","doi-asserted-by":"publisher","first-page":"e986","DOI":"10.4088\/JCP.16m11310","article-title":"Higher baseline proinflammatory cytokines mark poor antidepressant response in bipolar disorder","volume":"78","author":"Benedetti","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jad.2010.09.011","article-title":"Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study","volume":"129","author":"Berwaerts","year":"2011","journal-title":"J. Affect Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/01.wnr.0000220143.37036.32","article-title":"Insulin-like growth factor binding protein-2 expression is decreased by lithium","volume":"17","author":"Bezchlibnyk","year":"2006","journal-title":"Neuroreport"},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.brainres.2007.01.147","article-title":"Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment","volume":"1147","author":"Bezchlibnyk","year":"2007","journal-title":"Brain Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.3390\/cells9102276","article-title":"Understanding IGF-II action through insights into receptor binding and activation","volume":"9","author":"Blyth","year":"2020","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1038\/tp.2014.46","article-title":"Increased M1\/decreased M2 signature and signs of Th1\/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia","volume":"4","author":"Brambilla","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"B123","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","article-title":"Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder","volume":"116","author":"Brietzke","year":"2009","journal-title":"J. Affect Disord."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-023-03858-y","article-title":"Imbalance of plasma copper and zinc levels and the association between the Cu\/Zn ratio and lipid peroxidation in Algerian bipolar patients","volume":"19","author":"Chebieb","year":"2023","journal-title":"Biol. Trace Elem. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.21037\/apm-20-1967","article-title":"Peripheral IGF-1 in bipolar disorder and major depressive disorder: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1034\/j.1399-5618.2003.02237.x","article-title":"Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania","volume":"5","author":"Chengappa","year":"2003","journal-title":"Bipolar Disord."},{"key":"B19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jad.2020.05.158","article-title":"Increased proinflammatory cytokines, executive dysfunction, and reduced gray matter volumes in first-episode bipolar disorder and major depressive disorder","volume":"274","author":"Chen Mh","year":"2020","journal-title":"J. Affect Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jad.2015.10.056","article-title":"Association between the serotonin transporter and cytokines: implications for the pathophysiology of bipolar disorder","volume":"191","author":"Chou","year":"2016","journal-title":"J. Affect Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.pharmthera.2010.08.007","article-title":"The roles of TNF in brain dysfunction and disease","volume":"128","author":"Clark","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.psychres.2017.01.061","article-title":"Peripheral insulin-like growth factor 1 in bipolar disorder","volume":"250","author":"da Silva","year":"2017","journal-title":"Psychiatry Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/hup.2301","article-title":"Levels of TNF-\u03b1, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder","volume":"28","author":"Doganavsargil-Baysal","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.29399\/npa.24844","article-title":"Levels of TNF alpha, soluble TNF receptors (sTNF-R1, sTNF-R2) in bipolar disorder","volume":"57","author":"Do\u011fanav\u015fargil Baysal","year":"2019","journal-title":"Noro Psikiyatr. Ars"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.bbi.2011.03.013","article-title":"The activation of monocyte and T cell networks in patients with bipolar disorder","volume":"25","author":"Drexhage","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ygcen.2004.12.022","article-title":"Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions","volume":"142","author":"Duan","year":"2005","journal-title":"Gen. Comp. Endocrinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jpsychires.2020.06.010","article-title":"Plasma MCP-1 levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment","volume":"129","author":"Edberg","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.3390\/ijms24032215","article-title":"Chemokine dysregulation and neuroinflammation in schizophrenia: a systematic review","volume":"24","author":"Ermakov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40263-015-0275-6","article-title":"Diagnosis, epidemiology and management of mixed states in bipolar disorder","volume":"29","author":"Fagiolini","year":"2015","journal-title":"CNS Drugs"},{"key":"B122","doi-asserted-by":"publisher","first-page":"9591","DOI":"10.3390\/ijms23179591","article-title":"Insulin-like growth factor 2 (IGF-2) and Insulin-like growth factor binding protein 7 (IGFBP-7) are upregulated after atypical antipsychotics in Spanish schizophrenia patients","volume":"23","author":"Fern\u00e1ndez-Pereira","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"15254","DOI":"10.3390\/ijms242015254","article-title":"Protein plasma levels of the IGF signalling system are altered in major depressive disorder","volume":"24","author":"Fern\u00e1ndez-Pereira","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jad.2015.08.036","article-title":"Peripheral inflammation during abnormal mood states in bipolar I disorder","volume":"187","author":"Fiedorowicz","year":"2015","journal-title":"J. Affect Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"111035","DOI":"10.1016\/j.mce.2020.111035","article-title":"Disorders of IGFs and IGF-1R signaling pathways","volume":"518","author":"Forbes","year":"2020","journal-title":"Mol. Cell Endocrinol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"883927","DOI":"10.3389\/fneur.2022.883927","article-title":"Immune-inflammatory biomarkers predict cognition and social functioning in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: a 1-year follow-up study","volume":"13","author":"Gar\u00e9s-Caballer","year":"2022","journal-title":"Front. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e073591","DOI":"10.1136\/bmj-2022-073591","article-title":"Diagnosis and management of bipolar disorders","volume":"381","author":"Goes","year":"2023","journal-title":"BMJ"},{"key":"B33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jpsychires.2023.07.014","article-title":"Meta-analysis of soluble tumour necrosis factor receptors in severe mental illnesses","volume":"165","author":"Goh","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1007\/s11682-022-00636-7","article-title":"Association between resting-state functional connectivity of amygdala subregions and peripheral pro-inflammation cytokines levels in bipolar disorder","volume":"16","author":"Gong","year":"2022","journal-title":"Brain Imaging Behav."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-023-06089-1","article-title":"VEGF, IGF-1 and FGF-2 serum levels in children and adolescents with autism spectrum disorder with and without bipolar disorder","author":"Guldiken","year":"2023","journal-title":"J. Autism Dev. Disord."},{"key":"B36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jad.2012.04.044","article-title":"Evidence for an association between tumor necrosis factor-alpha levels and lithium response","volume":"143","author":"Guloksuz","year":"2012","journal-title":"J. Affect Disord."},{"key":"B37","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jad.2010.04.027","article-title":"Cytokine levels in euthymic bipolar patients","volume":"126","author":"Guloksuz","year":"2010","journal-title":"J. Affect Disord."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2023.01.001","article-title":"IGF2 inhibits hippocampal over-activated microglia and alleviates depression-like behavior in LPS- treated male mice","volume":"194","author":"Guo","year":"2023","journal-title":"Brain Res. Bull."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08977194.2011.640325","article-title":"Biology and significance of signalling pathways activated by IGF-II","volume":"30","author":"Harris","year":"2012","journal-title":"Growth factors."},{"key":"B40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.tins.2017.10.006","article-title":"The emerging neurobiology of bipolar disorder","volume":"41","author":"Harrison","year":"2018","journal-title":"Trends Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00213-004-2038-9","article-title":"Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium","volume":"179","author":"Himmerich","year":"2005","journal-title":"Psychopharmacol. Berl."},{"key":"B42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0893-133X(00)00089-0","article-title":"Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine","volume":"23","author":"Hinze-Selch","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/schbul\/sbw183","article-title":"A study of TNF pathway activation in schizophrenia and bipolar disorder in plasma and brain tissue","volume":"43","author":"Hoseth","year":"2017","journal-title":"Schizophr. Bull."},{"key":"B44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jad.2016.03.040","article-title":"Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - results from a prospective study","volume":"197","author":"Jacoby","year":"2016","journal-title":"J. Affect Disord."},{"key":"B124","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1503\/jpn.140183","article-title":"Monocyte and microglial activation in patients with mood-stabilized bipolar disorder","volume":"40","author":"Jakobsson","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"861881","DOI":"10.3389\/fpsyt.2022.861881","article-title":"Altered levels of plasma inflammatory cytokines and white matter integrity in bipolar disorder patients with suicide attempts","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/bdi.12980","article-title":"Oxidative stress parameters and antioxidants in patients with bipolar disorder: results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls","volume":"23","author":"Jim\u00e9nez-Fern\u00e1ndez","year":"2021","journal-title":"Bipolar Disord."},{"key":"B48","doi-asserted-by":"publisher","first-page":"20451253221135463","DOI":"10.1177\/20451253221135463","article-title":"Serum cytokine variations among inpatients with major depression, bipolar disorder, and schizophrenia versus healthy controls: a prospective 'true-to-life' study","volume":"13","author":"Junior","year":"2023","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"Kapczinski","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1017\/S1461145708009310","article-title":"Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs late-stage bipolar disorder","volume":"12","author":"Kauer-Sant'Anna","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J. Affect Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jad.2013.07.041","article-title":"High insulin-like growth factor-1 in patients with bipolar I disorder: a trait marker?","volume":"151","author":"Kim","year":"2013","journal-title":"J. Affect Disord."},{"key":"B53","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41398-019-0536-0","article-title":"Altered polyunsaturated fatty acid levels in relation to proinflammatory cytokines, fatty acid desaturase genotype, and diet in bipolar disorder","volume":"9","author":"Koga","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1176\/ajp.156.2.312","article-title":"Body weight and leptin plasma levels during treatment with antipsychotic drugs","volume":"156","author":"Kraus","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1590\/s1516-44462011000300010","article-title":"Serum levels of IL-6, IL-10 and TNF-\u03b1 in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance","volume":"33","author":"Kunz","year":"2011","journal-title":"Braz J. Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.dci.2003.09.006","article-title":"Chemokines","volume":"28","author":"Laing","year":"2004","journal-title":"Dev. Comp. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/14782715231197577","article-title":"Bipolar disorder: diagnosis, treatment and future directions","volume":"53","author":"Lane","year":"2023","journal-title":"J. R. Coll. Physicians Edinb"},{"key":"B128","doi-asserted-by":"publisher","first-page":"R11-5","DOI":"10.1677\/joe.0.171r011","article-title":"Lithium chloride inhibits the expression and secretion of insulin-like growth factor-binding protein-1","volume":"171","author":"Lewitt","year":"2001","journal-title":"J. Endocrinol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jad.2014.12.033","article-title":"IL-23 and TGF-\u03b21 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode","volume":"174","author":"Li","year":"2015","journal-title":"J. Affect Disord."},{"key":"B59","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.psychres.2014.03.042","article-title":"Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder","volume":"218","author":"Liu","year":"2014","journal-title":"Psychiatry Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e33439","DOI":"10.1097\/MD.0000000000033439","article-title":"IL-4 as a potential biomarker for differentiating major depressive disorder from bipolar depression","volume":"102","author":"Lu","year":"2023","journal-title":"Med. Baltim."},{"key":"B61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.psychres.2016.07.027","article-title":"Altered serum levels of TNF-\u03b1, IL-6 and IL-18 in manic, depressive, mixed state of bipolar disorder patients","volume":"244","author":"Luo","year":"2016","journal-title":"Psychiatry Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.neuropharm.2014.10.011","article-title":"Insulin-like growth factor 2 mitigates depressive behavior in a rat model of chronic stress","volume":"89","author":"Luo","year":"2015","journal-title":"Neuropharmacology"},{"key":"B120","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/eip.12906","article-title":"Correlations between immune and metabolic serum markers and schizophrenia\/bipolar disorder polygenic risk score in first-episode psychosis","volume":"14","author":"Maj","year":"2020","journal-title":"Early Interv. Psychiatry"},{"key":"B63","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/2327-6924.12275","article-title":"Diagnosis and treatment of patients with bipolar disorder: a review for advanced practice nurses","volume":"27","author":"McCormick","year":"2015","journal-title":"J. Am. Assoc. Nurse Pract."},{"key":"B64","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/15622975.2017.1282172","article-title":"Insulin-like growth factor binding protein 2 in bipolar disorder: an expression study in peripheral tissues","volume":"19","author":"Milanesi","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1159\/000527123","article-title":"The history of the insulin-like growth factor system","volume":"95","author":"Miller","year":"2022","journal-title":"Horm. Res. Paediatr."},{"key":"B66","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.bbi.2020.04.003","article-title":"TNF-\u03b1 and its soluble receptors mediate the relationship between prior severe mood episodes and cognitive dysfunction in euthymic bipolar disorder","volume":"88","author":"Millett","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"B67","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.bbi.2020.04.013","article-title":"Chemokine alterations in bipolar disorder: a systematic review and meta-analysis","volume":"88","author":"Misiak","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"B68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1677\/joe.0.1750019","article-title":"IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms","volume":"175","author":"Mohan","year":"2002","journal-title":"J. Endocrinol."},{"key":"B70","first-page":"363","article-title":"Bipolar disorder: clinical overview","volume":"39","author":"M\u00fcller","year":"2016","journal-title":"Med. Monatsschr Pharm."},{"key":"B71","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.psychres.2018.01.022","article-title":"Leukocytes in peripheral blood in patients with bipolar disorder - trait and state alterations and association with levels of cytokines and C-reactive protein","volume":"261","author":"Munkholm","year":"2018","journal-title":"Psychiatry Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.euroneuro.2022.06.002","article-title":"Peripheral versus central nervous system cytokine levels in bipolar disorder: do they converge on the same pathophysiological processes?","volume":"61","author":"Nascimento","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1001\/jama.2023.18588","article-title":"Diagnosis and treatment of bipolar disorder: a review","volume":"330","author":"Nierenberg","year":"2023","journal-title":"JAMA"},{"key":"B74","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","article-title":"Cytokine profiles in bipolar affective disorder: focus on acutely ill patients","volume":"90","author":"O'Brien","year":"2006","journal-title":"J. Affect Disord."},{"key":"B75","doi-asserted-by":"publisher","first-page":"861231","DOI":"10.1155\/2014\/861231","article-title":"Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity","volume":"2014","author":"Olmos","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"B76","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","article-title":"Immune variations in bipolar disorder: phasic differences","volume":"9","author":"Ortiz-Dom\u00ednguez","year":"2007","journal-title":"Bipolar Disord."},{"key":"B77","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.rcp.2015.06.002","article-title":"Comparison of inflammatory biomarkers between bipolar disorder I patients and control subjects","volume":"45","author":"Palacio","year":"2016","journal-title":"Rev. Colomb. Psiquiatr."},{"key":"B78","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pnpbp.2013.01.008","article-title":"Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients","volume":"44","author":"Palomino","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B79","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/bdi.12320","article-title":"Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder","volume":"17","author":"Pandey","year":"2015","journal-title":"Bipolar Disord."},{"key":"B80","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jad.2014.12.010","article-title":"Increased serum levels of eotaxin\/CCL11 in late-stage patients with bipolar disorder: an accelerated aging biomarker?","volume":"182","author":"Panizzutti","year":"2015","journal-title":"J. Affect Disord."},{"key":"B81","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1080\/15622975.2016.1259498","article-title":"sVCAM-1, sICAM-1, TNF-\u03b1 and IL-6 levels in bipolar disorder type I: acute, longitudinal and therapeutic implications","volume":"19","author":"Pantovi\u0107-Stefanovi\u0107","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2018.10.012","article-title":"Insulin growth factor 2 (IGF2) as an emergent target in psychiatric and neurological disorders. Review","volume":"149","author":"Pardo","year":"2019","journal-title":"Neurosci. Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ajmg.b.31153","article-title":"Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder","volume":"156","author":"Pereira","year":"2011","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B84","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jpsychires.2023.05.022","article-title":"Comparison of oxidative stress parameters, thiol-disulfide homeostasis, and pro-inflammatory cytokines levels in patients with bipolar disorder and their first-degree relatives","volume":"162","author":"Polat","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"100529","DOI":"10.1016\/j.bbih.2022.100529","article-title":"Long-term effect of childhood trauma: role of inflammation and white matter in mood disorders","volume":"26","author":"Poletti","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"key":"B86","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.7150\/thno.27882","article-title":"Microglial TLR4-dependent autophagy induces ischemic white matter damage via STAT1\/6 pathway","volume":"8","author":"Qin","year":"2018","journal-title":"Theranostics"},{"key":"B87","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.beem.2015.06.003","article-title":"Insulin-like growth factor binding-protein-3 (IGFBP-3)","volume":"29","author":"Ranke","year":"2015","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"B88","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000339949","article-title":"Selected cytokine profiles during remission in bipolar patients","volume":"66","author":"Remlinger-Molenda","year":"2012","journal-title":"Neuropsychobiology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1007\/s00213-019-5175-x","article-title":"Targeting the immune system in the treatment of bipolar disorder","volume":"236","author":"Rosenblat","year":"2019","journal-title":"Psychopharmacol. Berl."},{"key":"B90","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1192\/bjp.2018.144","article-title":"Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses","volume":"213","author":"Rowland","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"B91","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jpsychires.2017.03.018","article-title":"A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients","volume":"92","author":"Sayana","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s11920-014-0514-4","article-title":"Current state of biomarkers in bipolar disorder","volume":"16","author":"Scola","year":"2014","journal-title":"Curr. Psychiatry Rep."},{"key":"B93","volume-title":"Mood disorder","author":"Sekhon","year":"2023"},{"key":"B94","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1007\/s12035-016-0124-8","article-title":"Associations of serum cytokine receptor levels with melancholia, staging of illness, depressive and manic phases, and severity of depression in bipolar disorder","volume":"54","author":"Siwek","year":"","journal-title":"Mol. Neurobiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"469","DOI":"10.12740\/PP\/OnlineFirst\/65250","article-title":"The serum concentration of copper in bipolar disorder","volume":"51","author":"Siwek","year":"","journal-title":"Psychiatr. Pol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"964538","DOI":"10.3389\/fpsyt.2022.964538","article-title":"Interleukin-8 and tumor necrosis factor-alpha in youth with mood disorders-A longitudinal study","volume":"13","author":"Skibinska","year":"2022","journal-title":"Front. Psychiatry"},{"key":"B97","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbi.2021.07.014","article-title":"Peripheral levels of C-reactive protein, tumor necrosis factor-\u03b1, interleukin-6, and interleukin-1\u03b2 across the mood spectrum in bipolar disorder: a meta-analysis of mean differences and variability","volume":"97","author":"Solmi","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s12325-020-01581-x","article-title":"The roles of insulin-like growth factor binding protein family in development and diseases","volume":"38","author":"Song","year":"2021","journal-title":"Adv. Ther."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2013.04.004","article-title":"Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients","volume":"73","author":"Squassina","year":"2013","journal-title":"Pharmacol. Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neubiorev.2014.02.001","article-title":"Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies","volume":"42","author":"Stuart","year":"2014","journal-title":"Neurosci. Biobehav Rev."},{"key":"B101","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1186\/s12888-023-05330-6","article-title":"Comparison of olfactory function, cognitive function and serum tumor necrosis factor-\u03b1 between bipolar and schizophrenic patients in the remission stage","volume":"23","author":"Su","year":"2023","journal-title":"BMC Psychiatry"},{"key":"B102","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1742-2094-10-37","article-title":"Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators","volume":"10","author":"Suh","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"B103","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pnpbp.2017.04.028","article-title":"Clinical staging and serum cytokines in bipolar patients during euthymia","volume":"77","author":"Tatay-Manteiga","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B104","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/hup.2450","article-title":"Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment","volume":"30","author":"Teixeira","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1399-5618.2009.00726.x","article-title":"The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders","volume":"11","author":"Tohen","year":"2009","journal-title":"Bipolar Disord."},{"key":"B106","doi-asserted-by":"publisher","first-page":"e2411","DOI":"10.1097\/MD.0000000000002411","article-title":"Significantly higher peripheral insulin-like growth factor-1 levels in patients with major depressive disorder or bipolar disorder than in healthy controls: a meta-analysis and review under guideline of prisma","volume":"95","author":"Tu","year":"2016","journal-title":"Med. Baltim."},{"key":"B107","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3906\/sag-1907-70","article-title":"Neurotrophic factors in bipolar disorders patients with manic episode","volume":"50","author":"Tun\u00e7el","year":"2020","journal-title":"Turk J. Med. Sci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.psychres.2015.05.078","article-title":"Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment","volume":"228","author":"Uyanik","year":"2015","journal-title":"Psychiatry Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.psyneuen.2017.07.003","article-title":"Neurotrophic and inflammatory markers in bipolar disorder: a prospective study","volume":"84","author":"van den Ameele","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jad.2020.07.125","article-title":"Association of pro-inflammatory cytokines with clinical features in euthymic patients with Bipolar-I-Disorder","volume":"277","author":"Vares","year":"2020","journal-title":"J. Affect Disord."},{"key":"B112","doi-asserted-by":"publisher","first-page":"pyw012","DOI":"10.1093\/ijnp\/pyw012","article-title":"The differential levels of inflammatory cytokines and BDNF among bipolar spectrum disorders","volume":"19","author":"Wang","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/schbul\/sbaa159","article-title":"Reduced insulin-like growth factor family member expression predicts neurogenesis marker expression in the subependymal zone in schizophrenia and bipolar disorder","volume":"47","author":"Weissleder","year":"2021","journal-title":"Schizophr. Bull."},{"key":"B114","unstructured":"Institute of Health metrics and evaluation. Global Health data exchange (GHDx)2022"},{"key":"B115","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neulet.2014.07.040","article-title":"Pro-inflammatory cytokines and soluble receptors in response to acute psychosocial stress: differential reactivity in bipolar disorder","volume":"580","author":"Wieck","year":"2014","journal-title":"Neurosci. Lett."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1063479","DOI":"10.3389\/fpsyt.2022.1063479","article-title":"Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder?","volume":"13","author":"Wu","year":"2023","journal-title":"Front. Psychiatry"},{"key":"B117","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"B118","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/15622975.2021.1925152","article-title":"Cognition-immune interactions between executive function and working memory, tumour necrosis factor-alpha (TNF-alpha) and soluble TNF receptors (sTNFR1 and sTNFR2) in bipolar disorder","volume":"23","author":"Zazula","year":"2022","journal-title":"World J. Biol. Psychiatry"},{"key":"B119","doi-asserted-by":"publisher","first-page":"100441","DOI":"10.1016\/j.bbih.2022.100441","article-title":"Blood-brain barrier dysfunction in bipolar disorder: molecular mechanisms and clinical implications","volume":"21","author":"Zhao","year":"2022","journal-title":"Brain Behav. Immun. Health"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1384198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T04:25:11Z","timestamp":1713932711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1384198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":128,"alternative-id":["10.3389\/fphar.2024.1384198"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1384198","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"article-number":"1384198"}}